299 related articles for article (PubMed ID: 34642905)
1. Electrophysiological Biomarkers in Genetic Epilepsies.
Armstrong C; Marsh ED
Neurotherapeutics; 2021 Jul; 18(3):1458-1467. PubMed ID: 34642905
[TBL] [Abstract][Full Text] [Related]
2. STXBP1 as a therapeutic target for epileptic encephalopathy.
Stamberger H; Weckhuysen S; De Jonghe P
Expert Opin Ther Targets; 2017 Nov; 21(11):1027-1036. PubMed ID: 28971703
[TBL] [Abstract][Full Text] [Related]
3. Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies.
Palmer EE; Howell K; Scheffer IE
Neurotherapeutics; 2021 Jul; 18(3):1432-1444. PubMed ID: 34708325
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in neurometabolic diseases: The genetic role in the modern era.
Tein I
Epilepsy Behav; 2023 Aug; 145():109338. PubMed ID: 37453291
[TBL] [Abstract][Full Text] [Related]
5. Precision Treatments in Epilepsy.
Demarest S; Brooks-Kayal A
Neurotherapeutics; 2021 Jul; 18(3):1429-1431. PubMed ID: 34704188
[No Abstract] [Full Text] [Related]
6. STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy.
Stamberger H; Nikanorova M; Willemsen MH; Accorsi P; Angriman M; Baier H; Benkel-Herrenbrueck I; Benoit V; Budetta M; Caliebe A; Cantalupo G; Capovilla G; Casara G; Courage C; Deprez M; Destrée A; Dilena R; Erasmus CE; Fannemel M; Fjær R; Giordano L; Helbig KL; Heyne HO; Klepper J; Kluger GJ; Lederer D; Lodi M; Maier O; Merkenschlager A; Michelberger N; Minetti C; Muhle H; Phalin J; Ramsey K; Romeo A; Schallner J; Schanze I; Shinawi M; Sleegers K; Sterbova K; Syrbe S; Traverso M; Tzschach A; Uldall P; Van Coster R; Verhelst H; Viri M; Winter S; Wolff M; Zenker M; Zoccante L; De Jonghe P; Helbig I; Striano P; Lemke JR; Møller RS; Weckhuysen S
Neurology; 2016 Mar; 86(10):954-62. PubMed ID: 26865513
[TBL] [Abstract][Full Text] [Related]
7. Personalized medicine in genetic epilepsies - possibilities, challenges, and new frontiers.
Helbig I; Ellis CA
Neuropharmacology; 2020 Aug; 172():107970. PubMed ID: 32413583
[TBL] [Abstract][Full Text] [Related]
8. Precision medicine and therapies of the future.
Sisodiya SM
Epilepsia; 2021 Mar; 62 Suppl 2(Suppl 2):S90-S105. PubMed ID: 32776321
[TBL] [Abstract][Full Text] [Related]
9. Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.
Isom LL; Knupp KG
Neurotherapeutics; 2021 Jul; 18(3):1524-1534. PubMed ID: 34378168
[TBL] [Abstract][Full Text] [Related]
10. Personalized translational epilepsy research - Novel approaches and future perspectives: Part II: Experimental and translational approaches.
Bauer S; van Alphen N; Becker A; Chiocchetti A; Deichmann R; Deller T; Freiman T; Freitag CM; Gehrig J; Hermsen AM; Jedlicka P; Kell C; Klein KM; Knake S; Kullmann DM; Liebner S; Norwood BA; Omigie D; Plate K; Reif A; Reif PS; Reiss Y; Roeper J; Ronellenfitsch MW; Schorge S; Schratt G; Schwarzacher SW; Steinbach JP; Strzelczyk A; Triesch J; Wagner M; Walker MC; von Wegner F; Rosenow F
Epilepsy Behav; 2017 Nov; 76():7-12. PubMed ID: 28917498
[TBL] [Abstract][Full Text] [Related]
11. From Genetic Testing to Precision Medicine in Epilepsy.
Striano P; Minassian BA
Neurotherapeutics; 2020 Apr; 17(2):609-615. PubMed ID: 31981099
[TBL] [Abstract][Full Text] [Related]
12. Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies.
Guerrini R; Balestrini S; Wirrell EC; Walker MC
Neurology; 2021 Oct; 97(17):817-831. PubMed ID: 34493617
[TBL] [Abstract][Full Text] [Related]
13. Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.
Brock DC; Demarest S; Benke TA
Neurotherapeutics; 2021 Jul; 18(3):1445-1457. PubMed ID: 34595733
[TBL] [Abstract][Full Text] [Related]
14. From next-generation sequencing to targeted treatment of non-acquired epilepsies.
Møller RS; Hammer TB; Rubboli G; Lemke JR; Johannesen KM
Expert Rev Mol Diagn; 2019 Mar; 19(3):217-228. PubMed ID: 30661434
[TBL] [Abstract][Full Text] [Related]
15. Precision therapy in the genetic epilepsies of childhood.
Byrne S; Enright N; Delanty N
Dev Med Child Neurol; 2021 Nov; 63(11):1276-1282. PubMed ID: 34089185
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study.
Cutri-French C; Armstrong D; Saby J; Gorman C; Lane J; Fu C; Peters SU; Percy A; Neul JL; Marsh ED
Ann Neurol; 2020 Aug; 88(2):396-406. PubMed ID: 32472944
[TBL] [Abstract][Full Text] [Related]
17. Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment.
Thakran S; Guin D; Singh P; Singh P; Kukal S; Rawat C; Yadav S; Kushwaha SS; Srivastava AK; Hasija Y; Saso L; Ramachandran S; Kukreti R
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096746
[TBL] [Abstract][Full Text] [Related]
18. Precision medicine in genetic epilepsies: break of dawn?
Reif PS; Tsai MH; Helbig I; Rosenow F; Klein KM
Expert Rev Neurother; 2017 Apr; 17(4):381-392. PubMed ID: 27781560
[TBL] [Abstract][Full Text] [Related]
19. Epileptic encephalopathies and progressive neurodegeneration.
Guerrini R; Conti V
Rev Neurol (Paris); 2024 May; 180(5):363-367. PubMed ID: 38582661
[TBL] [Abstract][Full Text] [Related]
20. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long-term outcome.
Bar C; Kuchenbuch M; Barcia G; Schneider A; Jennesson M; Le Guyader G; Lesca G; Mignot C; Montomoli M; Parrini E; Isnard H; Rolland A; Keren B; Afenjar A; Dorison N; Sadleir LG; Breuillard D; Levy R; Rio M; Dupont S; Negrin S; Danieli A; Scalais E; De Saint Martin A; El Chehadeh S; Chelly J; Poisson A; Lebre AS; Nica A; Odent S; Sekhara T; Brankovic V; Goldenberg A; Vrielynck P; Lederer D; Maurey H; Terrone G; Besmond C; Hubert L; Berquin P; Billette de Villemeur T; Isidor B; Freeman JL; Mefford HC; Myers CT; Howell KB; Rodríguez-Sacristán Cascajo A; Meyer P; Genevieve D; Guët A; Doummar D; Durigneux J; van Dooren MF; de Wit MCY; Gerard M; Marey I; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
Epilepsia; 2020 Nov; 61(11):2461-2473. PubMed ID: 32954514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
